Who has resigned from Johnson & Johnson?

Ashley McEvoy, Executive Vice President, Worldwide Chair MedTech, has resigned from her position.

When was the resignation effective?

The resignation was effective October 20, 2023.

Will Ashley McEvoy continue to work for JNJ in any capacity?

Yes, Ms. McEvoy will stay with the company through the first quarter of 2024 to ensure a smooth transition.

What is the significance of this leadership change?

This is a notable change in leadership for Johnson & Johnson's MedTech segment, a key area of the company's business. Investors will be looking for information on the interim or permanent replacement and how this transition might affect the segment's strategy and performance.

JNJ 8-K: Leadership Changes

Summary

Johnson & Johnson (JNJ) announced a significant leadership change within its MedTech segment via an 8-K filing dated October 23, 2023. Ashley McEvoy, Executive Vice President and Worldwide Chair of MedTech, has resigned from her position, effective October 20, 2023. She will remain with the company until the first quarter of 2024 to facilitate a transition period. This departure marks the end of her tenure on the Executive Committee and represents a notable change in leadership for a key segment of the company's operations.

Key Highlights

1Resignation of Ashley McEvoy as EVP, Worldwide Chair MedTech, effective October 20, 2023.
2Ms. McEvoy will remain with JNJ through the first quarter of 2024 for transition purposes.
3Her departure from the Executive Committee is effective immediately.
4The company has attached a press release related to this announcement as Exhibit 99.1 to the 8-K filing.
5This change impacts the leadership of Johnson & Johnson's MedTech segment.

JOHNSON & JOHNSON 8-K Report, Executive Changes (Oct 23, 2023)

Summary

Key Highlights

Frequently Asked Questions